jRCT1031220112
Untitled Trial
Japan post marketing study of Peficitinib use in RA patients study switch
Astellas Pharma Inc.·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Rheumatoid arthritis
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Astellas Pharma Inc.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT1031220112
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT1031220112 through Pure Global AI's free database. This phase not specified trial is sponsored by Astellas Pharma Inc. and is currently Recruiting. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.